Cargando…

Temporal Dispersion and Duration of the Distal Compound Muscle Action Potential Do Not Distinguish Diabetic Sensorimotor Polyneuropathy From Chronic Inflammatory Demyelinating Polyneuropathy

OBJECTIVE: To investigate the contribution of duration and temporal dispersion (TD) of the distal compound muscle action potential (CMAP) in discriminating chronic inflammatory demyelinating polyneuropathy (CIDP) from diabetic sensorimotor polyneuropathy (DSP) and from CIDP+DSP. METHODS: We performe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alcantara, Monica, Ngo, Mylan, de la Cruz, James, Menon, Deepak, Barnett-Tapia, Carolina, Katzberg, Hans, Bril, Vera
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087194/ https://www.ncbi.nlm.nih.gov/pubmed/35557614 http://dx.doi.org/10.3389/fneur.2022.872762

Ejemplares similares

Electrophysiological Responsiveness to Long-Term Therapy in Chronic Inflammatory Demyelinating Polyneuropathy: Case Report
por: Khomand, Payam, et al.
Publicado: (2020)

Comparison of diabetes patients with “demyelinating” diabetic sensorimotor polyneuropathy to those diagnosed with CIDP
por: Dunnigan, Samantha K, et al.
Publicado: (2013)

Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetes
por: Breiner, Ari, et al.
Publicado: (2019)

Conduction Slowing in Diabetic Sensorimotor Polyneuropathy
por: Dunnigan, Samantha K., et al.
Publicado: (2013)

The Characteristics of Chronic Inflammatory Demyelinating Polyneuropathy in Patients with and without Diabetes – An Observational Study
por: Dunnigan, Samantha K., et al.
Publicado: (2014)

Ranirestat for the Management of Diabetic Sensorimotor Polyneuropathy
por: Bril, Vera, et al.
Publicado: (2009)

Measurement of Cooling Detection Thresholds for Identification of Diabetic Sensorimotor Polyneuropathy in Type 1 Diabetes
por: Lysy, Zoe, et al.
Publicado: (2014)

Identification and Prediction of Diabetic Sensorimotor Polyneuropathy Using Individual and Simple Combinations of Nerve Conduction Study Parameters
por: Weisman, Alanna, et al.
Publicado: (2013)

Detection of Diabetic Sensorimotor Polyneuropathy by Corneal Confocal Microscopy in Type 1 Diabetes: A concurrent validity study
por: Ahmed, Ausma, et al.
Publicado: (2012)

The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy
por: Bril, Vera, et al.
Publicado: (2016)

Heart Rate Variability and Sensorimotor Polyneuropathy in Type 1 Diabetes
por: Orlov, Steven, et al.
Publicado: (2012)

Reproducibility of In Vivo Corneal Confocal Microscopy Using an Automated Analysis Program for Detection of Diabetic Sensorimotor Polyneuropathy
por: Ostrovski, Ilia, et al.
Publicado: (2015)

Comparison of monoclonal gammopathy of undetermined significance-associated neuropathy and chronic inflammatory demyelinating polyneuropathy patients
por: Alkhawajah, Nuha M., et al.
Publicado: (2014)

Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy
por: Bril, V, et al.
Publicado: (2009)

Randomized trial of three IVIg doses for treating chronic inflammatory demyelinating polyneuropathy
por: Cornblath, David R, et al.
Publicado: (2022)

Depression with Chronic Inflammatory Demyelinating Polyneuropathy
por: Marwale, Arun, et al.
Publicado: (2018)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021)

The sensitivity and specificity of the neurological examination in polyneuropathy patients with clinical and electrophysiological correlations
por: Abraham, Alon, et al.
Publicado: (2017)

Axonal swellings are related to type 2 diabetes, but not to distal diabetic sensorimotor polyneuropathy
por: Karlsson, Pall, et al.
Publicado: (2021)

Diabetic Distal Symmetric Sensorimotor Polyneuropathy: A Proposal of New Electrodiagnostic Evaluation
por: Lee, Hang Jae, et al.
Publicado: (2023)

Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre‐randomization phase of the Polyneuropathy And Treatment with Hizentra study
por: Mielke, Orell, et al.
Publicado: (2019)

Endometrial Carcinoma Presenting as Vasculitic Sensorimotor Polyneuropathy
por: Vasku, Marketa, et al.
Publicado: (2011)

Subacute Sensorimotor Polyneuropathy Associated with Autoimmune Hepatitis
por: Park, Kee Hong, et al.
Publicado: (2016)

Idiopathic CD4 lymphocytopenia with sensorimotor polyneuropathy
por: Puri, Vinod, et al.
Publicado: (2016)

A Case of Paraneoplastic Demyelinating Motor Polyneuropathy
por: Mostoufizadeh, Sohrab, et al.
Publicado: (2012)

Tailoring of therapy for chronic inflammatory demyelinating polyneuropathy
por: Rajabally, Yusuf A.
Publicado: (2015)

Challenges in the diagnosis of chronic inflammatory demyelinating polyneuropathy
por: Allen, Jeffrey A., et al.
Publicado: (2018)

Safety and Tolerability of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: Results of the ProCID Study
por: Cornblath, David R., et al.
Publicado: (2023)

Nerve Ultrasound Comparison Between Transthyretin Familial Amyloid Polyneuropathy and Chronic Inflammatory Demyelinating Polyneuropathy
por: Du, Kang, et al.
Publicado: (2021)

Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review
por: Lewis, Richard A., et al.
Publicado: (2020)

IRIS manifesting as chronic inflammatory demyelinating polyneuropathy in HIV
por: Reghukumar, Aravind, et al.
Publicado: (2014)

Chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus
por: Fatehi, Farzad, et al.
Publicado: (2013)

Chronic Acquired Demyelinating Polyneuropathy following Renal Transplantation
por: Younger, D. S., et al.
Publicado: (2013)

Fibrillary glomerulonephritis combined with chronic inflammatory demyelinating polyneuropathy
por: Sung, Woo Kyung, et al.
Publicado: (2015)

Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy
por: Stettner, Mark, et al.
Publicado: (2015)

Inflammatory demyelinating polyneuropathy after total hip arthroplasty
por: Hess, Shane R., et al.
Publicado: (2018)

Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy
por: Rajabally, Yusuf A, et al.
Publicado: (2020)

Treatment-related fluctuations in subacute inflammatory demyelinating polyneuropathy
por: Min, Young Gi, et al.
Publicado: (2020)

Underdiagnosis and diagnostic delay in chronic inflammatory demyelinating polyneuropathy
por: Chaudhary, Umair J., et al.
Publicado: (2020)

Subcutaneous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy
por: Goyal, Namita A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jaobp6rgsv7i68ff59icikn2av